Immune reconstitution inflammatory syndromes;Immunrekonstitutionelle inflammatorische syndrome

MMW-Fortschritte der Medizin

Volumn 145, Issue SUPPL. 1, 2003, Pages 42-47

  Stoll, Matthias ^a   Heiken, H ^a   Weber, K ^a   Hundt, M ^a   Behrens, G ^a   Schmidt, R E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antiretroviral therapy; HIV infection; Immune reconstitution

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PENTOXIFYLLINE; 5 HYDROXYINDOLEACETIC ACID;

AUTOIMMUNE DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LONG TERM CARE; MORBIDITY; MORTALITY; PREVALENCE; PROGNOSIS; SHORT SURVEY; TREATMENT OUTCOME; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; OPPORTUNISTIC INFECTION; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYDROXYINDOLEACETIC ACID; OPPORTUNISTIC INFECTIONS; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 3242704184     PISSN: 14383276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (0)